Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cell Therapy Market, by Therapy Type
1.4.2 North America Cell Therapy Market, by Therapeutic Area
1.4.3 North America Cell Therapy Market, by End User
1.4.4 North America Cell Therapy Market, by Cell Type
1.4.5 North America Cell Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals & Trials
3.2.5 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. North America Cell Therapy Market by Therapy Type
4.1 North America Autologous Market by Country
4.2 North America Allogeneic Market by Country
Chapter 5. North America Cell Therapy Market by Therapeutic Area
5.1 North America Malignancies Market by Country
5.2 North America Autoimmune Disorders Market by Country
5.3 North America Musculoskeletal Disorders Market by Country
5.4 North America Dermatology Market by Country
5.5 North America Other Therapeutic Area Market by Country
Chapter 6. North America Cell Therapy Market by Therapy Type
6.1 North America Academic & Research Institutes Market by Country
6.2 North America Hospitals & Clinics Market by Country
Chapter 7. North America Cell Therapy Market by Cell Type
7.1 North America Stem Cell Market by Country
7.2 North America Umbilical Cord-Derived Cell Market by Country
7.3 North America Adipose-Derived Stem Cell Market by Country
7.4 North America Non-Stem Cell Market by Country
7.5 North America Bone Marrow Cell Market by Country
7.6 North America Blood Cell Market by Country
7.7 North America Others Cell Market by Country
Chapter 8. North America Cell Therapy Market by Country
8.1 US Cell Therapy Market
8.1.1 US Cell Therapy Market by Therapy Type
8.1.2 US Cell Therapy Market by Therapeutic Area
8.1.3 US Cell Therapy Market by End User
8.1.4 US Cell Therapy Market by Cell Type
8.2 Canada Cell Therapy Market
8.2.1 Canada Cell Therapy Market by Therapy Type
8.2.2 Canada Cell Therapy Market by Therapeutic Area
8.2.3 Canada Cell Therapy Market by End User
8.2.4 Canada Cell Therapy Market by Cell Type
8.3 Mexico Cell Therapy Market
8.3.1 Mexico Cell Therapy Market by Therapy Type
8.3.2 Mexico Cell Therapy Market by Therapeutic Area
8.3.3 Mexico Cell Therapy Market by End User
8.3.4 Mexico Cell Therapy Market by Cell Type
8.4 Rest of North America Cell Therapy Market
8.4.1 Rest of North America Cell Therapy Market by Therapy Type
8.4.2 Rest of North America Cell Therapy Market by Therapeutic Area
8.4.3 Rest of North America Cell Therapy Market by End User
8.4.4 Rest of North America Cell Therapy Market by Cell Type
Chapter 9. Company Profiles
9.1 Fujifilm Holdings Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.2 Smith & Nephew PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Kolon TissueGene, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Approvals & Trials:
9.4 JCR Pharmaceuticals Co., Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Acquisition and Mergers:
9.4.4.3 Approvals & Trials:
9.5 Medipost Co., Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Partnerships, Collaborations, and Agreements:
9.5.3.2 Approvals & Trials:
9.6 Stemedica Cell Technologies, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Approvals & Trials:
9.7 NuVasive, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Geographical Expansions:
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. Pharmicell Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expense
9.10.4 Recent strategies and developments:
9.10.4.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
